| Bioactivity | GERI-BP002-A is an inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT) produced by Aspergillus fumigatus F93, which can be used in cancer research[1]. | ||||||
| Invitro | GERI-BP002-A 对 A549、SKOV-3、HCT-15、XF-498 和 SKMEL-2 细胞具有细胞毒性，其 ED50 值分别为 5.45 μg/mL、8.83 μg/mL、5.79 μg/mL、7.30 μg/mL 和 5.39 μg/mL[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> GERI-BP002-A 相关抗体: | ||||||
| CAS | 119-47-1 | ||||||
| Formula | C23H32O2 | ||||||
| Molar Mass | 340.50 | ||||||
| Appearance | 固体 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | RT, stored under nitrogen
|
||||||
| Reference | [1]. Kim Y K, et al. GERI-BP002-A, novel inhibitor of acyl-CoA: cholesterol acyltransferase produced by Aspergillus fumigatus F93[J]. The Journal of Antibiotics, 1996, 49(1): 31-36. |